VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 122 filers reported holding VERVE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $563,550 | -60.3% | 42,500 | -43.8% | 0.00% | -100.0% |
| Q2 2023 | $1,418,813 | +24.9% | 75,670 | -3.9% | 0.00% | – |
| Q1 2023 | $1,135,863 | -25.6% | 78,770 | -0.1% | 0.00% | -100.0% |
| Q4 2022 | $1,526,135 | -39.8% | 78,870 | +6.9% | 0.00% | 0.0% |
| Q3 2022 | $2,534,000 | +312.7% | 73,770 | +83.5% | 0.00% | – |
| Q2 2022 | $614,000 | -21.1% | 40,200 | +17.9% | 0.00% | – |
| Q1 2022 | $778,000 | +52.8% | 34,100 | +147.1% | 0.00% | – |
| Q4 2021 | $509,000 | -32.3% | 13,800 | -13.8% | 0.00% | – |
| Q3 2021 | $752,000 | +100.5% | 16,000 | +157.3% | 0.00% | – |
| Q2 2021 | $375,000 | – | 6,219 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 2,508,809 | $57,251,000 | 8.18% |
| Alphabet Inc. | 10,974,011 | $250,427,000 | 8.12% |
| M28 Capital Management LP | 178,500 | $4,073,000 | 3.74% |
| Casdin Capital, LLC | 3,138,167 | $71,613,000 | 3.21% |
| Ally Bridge Group (NY) LLC | 105,360 | $2,404,000 | 1.78% |
| Redmile Group, LLC | 1,835,328 | $41,882,000 | 1.31% |
| Cormorant Asset Management, LP | 700,710 | $15,990,000 | 1.23% |
| Novo Holdings A/S | 750,000 | $17,115,000 | 0.90% |
| Artal Group S.A. | 400,000 | $9,128,000 | 0.38% |
| PFM Health Sciences, LP | 369,765 | $8,438,000 | 0.32% |